Tocotrienol Against the Progression of End Stage Liver Disease

Clinical trial NCT02581085 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02581085
Sponsor: Chandan Sen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

End Stage Liver Disease NASH - Nonalcoholic Steatohepatitis NAFLD - Nonalcoholic Fatty Liver Disease

Start date: 2019-11-01
Primary completion: 2026-12-16
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.